Antipsychotic drugs and their side-effects:
Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiol...
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London [u.a.]
Acad. Press
1993
|
| Schriftenreihe: | Neuroscience perspectives
|
| Schlagworte: | |
| Zusammenfassung: | Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XVI, 285 S. graph. Darst. |
| ISBN: | 0120790351 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV010269962 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 950626s1993 d||| |||| 00||| eng d | ||
| 020 | |a 0120790351 |9 0-12-079035-1 | ||
| 035 | |a (OCoLC)29762112 | ||
| 035 | |a (DE-599)BVBBV010269962 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-20 | ||
| 050 | 0 | |a RM333.5 | |
| 082 | 0 | |a 615/.788 |2 20 | |
| 082 | 0 | |a 615.5 |2 12a | |
| 084 | |a XI 5820 |0 (DE-625)153018:12926 |2 rvk | ||
| 245 | 1 | 0 | |a Antipsychotic drugs and their side-effects |c ed. by Thomas R. E. Barnes |
| 264 | 1 | |a London [u.a.] |b Acad. Press |c 1993 | |
| 300 | |a XVI, 285 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Neuroscience perspectives | |
| 500 | |a Literaturangaben | ||
| 520 | 3 | |a Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas | |
| 520 | |a Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose | ||
| 520 | |a However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen | ||
| 650 | 4 | |a Humans - Nervous system - Effects of - Drugs | |
| 650 | 7 | |a Antipsicóticos (aplicações terapêuticas) |2 larpcal | |
| 650 | 7 | |a Antipsicóticos (farmacologia) |2 larpcal | |
| 650 | 7 | |a Antipsychotische geneesmiddelen |2 gtt | |
| 650 | 7 | |a Bijwerkingen |2 gtt | |
| 650 | 7 | |a Drogas de abuso (complicações) |2 larpcal | |
| 650 | 7 | |a Drogas de abuso (efeitos) |2 larpcal | |
| 650 | 4 | |a Antipsychotic Agents |x adverse effects | |
| 650 | 4 | |a Antipsychotic Agents |x pharmacology | |
| 650 | 4 | |a Antipsychotic Agents |x therapeutic use | |
| 650 | 4 | |a Psychotropic drugs |x Complications | |
| 650 | 4 | |a Psychotropic drugs |x Side effects | |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 0 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Barnes, Thomas R. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006831758 | ||
Datensatz im Suchindex
| _version_ | 1804124684153782272 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010269962 |
| callnumber-first | R - Medicine |
| callnumber-label | RM333 |
| callnumber-raw | RM333.5 |
| callnumber-search | RM333.5 |
| callnumber-sort | RM 3333.5 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | XI 5820 |
| ctrlnum | (OCoLC)29762112 (DE-599)BVBBV010269962 |
| dewey-full | 615/.788 615.5 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.788 615.5 |
| dewey-search | 615/.788 615.5 |
| dewey-sort | 3615 3788 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03088nam a2200565 c 4500</leader><controlfield tag="001">BV010269962</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">950626s1993 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0120790351</subfield><subfield code="9">0-12-079035-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)29762112</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010269962</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM333.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.788</subfield><subfield code="2">20</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.5</subfield><subfield code="2">12a</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5820</subfield><subfield code="0">(DE-625)153018:12926</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antipsychotic drugs and their side-effects</subfield><subfield code="c">ed. by Thomas R. E. Barnes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 285 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neuroscience perspectives</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Humans - Nervous system - Effects of - Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsicóticos (aplicações terapêuticas)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsicóticos (farmacologia)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsychotische geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bijwerkingen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogas de abuso (complicações)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogas de abuso (efeitos)</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="x">Side effects</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barnes, Thomas R.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006831758</subfield></datafield></record></collection> |
| id | DE-604.BV010269962 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:49:34Z |
| institution | BVB |
| isbn | 0120790351 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006831758 |
| oclc_num | 29762112 |
| open_access_boolean | |
| owner | DE-20 |
| owner_facet | DE-20 |
| physical | XVI, 285 S. graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Acad. Press |
| record_format | marc |
| series2 | Neuroscience perspectives |
| spelling | Antipsychotic drugs and their side-effects ed. by Thomas R. E. Barnes London [u.a.] Acad. Press 1993 XVI, 285 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Neuroscience perspectives Literaturangaben Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen Humans - Nervous system - Effects of - Drugs Antipsicóticos (aplicações terapêuticas) larpcal Antipsicóticos (farmacologia) larpcal Antipsychotische geneesmiddelen gtt Bijwerkingen gtt Drogas de abuso (complicações) larpcal Drogas de abuso (efeitos) larpcal Antipsychotic Agents adverse effects Antipsychotic Agents pharmacology Antipsychotic Agents therapeutic use Psychotropic drugs Complications Psychotropic drugs Side effects Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 s Arzneimittelnebenwirkung (DE-588)4003134-2 s DE-604 Barnes, Thomas R. Sonstige oth |
| spellingShingle | Antipsychotic drugs and their side-effects Humans - Nervous system - Effects of - Drugs Antipsicóticos (aplicações terapêuticas) larpcal Antipsicóticos (farmacologia) larpcal Antipsychotische geneesmiddelen gtt Bijwerkingen gtt Drogas de abuso (complicações) larpcal Drogas de abuso (efeitos) larpcal Antipsychotic Agents adverse effects Antipsychotic Agents pharmacology Antipsychotic Agents therapeutic use Psychotropic drugs Complications Psychotropic drugs Side effects Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| subject_GND | (DE-588)4003134-2 (DE-588)4047729-0 |
| title | Antipsychotic drugs and their side-effects |
| title_auth | Antipsychotic drugs and their side-effects |
| title_exact_search | Antipsychotic drugs and their side-effects |
| title_full | Antipsychotic drugs and their side-effects ed. by Thomas R. E. Barnes |
| title_fullStr | Antipsychotic drugs and their side-effects ed. by Thomas R. E. Barnes |
| title_full_unstemmed | Antipsychotic drugs and their side-effects ed. by Thomas R. E. Barnes |
| title_short | Antipsychotic drugs and their side-effects |
| title_sort | antipsychotic drugs and their side effects |
| topic | Humans - Nervous system - Effects of - Drugs Antipsicóticos (aplicações terapêuticas) larpcal Antipsicóticos (farmacologia) larpcal Antipsychotische geneesmiddelen gtt Bijwerkingen gtt Drogas de abuso (complicações) larpcal Drogas de abuso (efeitos) larpcal Antipsychotic Agents adverse effects Antipsychotic Agents pharmacology Antipsychotic Agents therapeutic use Psychotropic drugs Complications Psychotropic drugs Side effects Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| topic_facet | Humans - Nervous system - Effects of - Drugs Antipsicóticos (aplicações terapêuticas) Antipsicóticos (farmacologia) Antipsychotische geneesmiddelen Bijwerkingen Drogas de abuso (complicações) Drogas de abuso (efeitos) Antipsychotic Agents adverse effects Antipsychotic Agents pharmacology Antipsychotic Agents therapeutic use Psychotropic drugs Complications Psychotropic drugs Side effects Arzneimittelnebenwirkung Psychopharmakon |
| work_keys_str_mv | AT barnesthomasr antipsychoticdrugsandtheirsideeffects |